secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK:        0001595097
Form:       8-K
Filed at:   2021-08-18T23:59:59+00:00
Accession:  0001493152-21-020508
Event type: leadership
Sentiment:  negative
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Corbus CMO Barbara White resigns to accept another position, effective Sep 17
-----------------------------------------------------------------------------

- Dr. Barbara White, Chief Medical Officer and Head of Research, resigns to join another company.
- Her last day with Corbus will be September 17, 2021.
- No replacement has been announced; separation agreement terms to be disclosed later.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595097/000149315221020508/0001493152-21-020508-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595097/000149315221020508/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-020508

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer